FDA Drugs recall ·
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only… recall
- Recall number
- D-0733-2026
- Date
- (initiated July 23, 2026)
- Company / brand
- Aurobindo Pharma USA Inc
279 Princeton Hightstown Rd, East Windsor, NJ, United States - Category
- Drugs › Class II
- Classification
- Class II
- Status
- Ongoing
- Units affected
- 6,408 bottles distributed to market
- Initiated by
- Voluntary: Firm initiated
Read the official FDA notice ↗
Product
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
Why was it recalled?
shortfill; reports of empty capsules.
What should you do?
FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.
Product codes & lot numbers
Batch # DMC125018A, Exp Date: 07/2027.
Distribution
US Nationwide.
What does Class II mean?
Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.
Source: FDA (drugs), recall D-0733-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.